Skip to main content
. 2022 Feb 28;15(1):14–25. doi: 10.15283/ijsc22008

Table 1.

Summary of oligodendrocyte differentiation

Species Cell sources Regional identity Target cell type (Efficiency) Duration (Days) Self-renewal In vitro disease modeling In vivo transplantation References
Human hESCs Spinal Cord PDGFRα OPCs (>80%) >90 days
Not shown Not shown Newborn shiverer mice Hu et al., 2009
MBP OLs (Not shown) >120 days
Mouse EpiSCs Spinal Cord PDGFRα OPCs (∼90%) >10 days >passage 8 Not shown Newborn shiverer mice Najm et al., 2011
MBP OLs (Not shown) >13 days
Human hESCs
hiPSCs
Spinal Cord PDGFRα OPCs (>30%) >120 days
Not shown Not shown (Schizophrenia, as shown in Windrem et al., 2017; Huntington’s Disease, as shown in Osipovitch et al., 2019) Newborn shiverer mice Wang et al.,
2013
MBP OLs (Not shown) ∼200 days
Human hESCs Forebrain
Spinal Cord
NG2 OPCs (∼87%) >120 days
Not shown Not shown (As shown in Djelloul et al., 2015) Not shown Stacpoole et al., 2013
MBP OLs (∼5%) >135 days
Human hESCs
hiPSCs
Spinal Cord O4 OPCs (∼70%) >50 days Not shown Not shown (Pelizaeus-Merzbacher Disease, as shown in Nevin., 2017; Schizophrenias, as shown in McPhie et al., 2018; Alexander disease, as shown in Li et al., 2018) Newborn shiverer mice Douvaras et al., 2014 and 2015
MBP OLs (∼20%) ∼75 days
Human hESCs
hiPSCs
Forebrain PDGFRα OPCs (25%) >50 days
Not shown Not shown Irradiated rats Piao et al., 2015
MBP OLs (Not shown) >85 days
Monkey
Human
mESCs
hiPSCs
Spinal Cord PDGFRα OPCs (>10%) >57 days
Not shown Not shown Newborn C57BL6/J mice Yamashita et al., 2017
MBP OLs (∼4%) >73 days
Human hESCs Not shown PDGFRα OPCs (>90%) >28 days Not shown Not shown Adult rat spinal cord Kim et al., 2017
Human hESCs
hiPSCs
Hindbrain PDGFRα OPCs (>20%) >65 days Not shown Not shown Adult shiverer mice Yun et al., 2019
MBP OLs
(>3%)
∼120 days